Cargando…

Long noncoding RNA MIR31HG and its splice variants regulate proliferation and migration: prognostic implications for muscle invasive bladder cancer

BACKGROUND: Growing evidence supports the pivotal role of long non-coding RNAs (lncRNAs) in the regulation of cancer development and progression. Their expression patterns and biological function in muscle invasive bladder cancer (MIBC) remain elusive. METHODS: Transcript levels of lncRNA miR-31 hos...

Descripción completa

Detalles Bibliográficos
Autores principales:	Wu, Sheng, Nitschke, Katja, Worst, Thomas Stefan, Fierek, Alexander, Weis, Cleo-Aron, Eckstein, Markus, Porubsky, Stefan, Kriegmair, Maximilian, Erben, Philipp
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	BioMed Central 2020
Materias:	Research
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7745499/ https://www.ncbi.nlm.nih.gov/pubmed/33334367 http://dx.doi.org/10.1186/s13046-020-01795-5

Ejemplares similares

ANLN and TLE2 in Muscle Invasive Bladder Cancer: A Functional and Clinical Evaluation Based on In Silico and In Vitro Data
por: Wu, Sheng, et al.
Publicado: (2019)

POFUT1 mRNA expression as an independent prognostic parameter in muscle-invasive bladder cancer
por: Wahby, Sarah, et al.
Publicado: (2020)

Subtype specific expression and survival prediction of pivotal lncRNAs in muscle invasive bladder cancer
por: Rinaldetti, Sebastien, et al.
Publicado: (2020)

RNA Expression of DNA Damage Response Genes in Muscle-Invasive Bladder Cancer: Influence on Outcome and Response to Adjuvant Cisplatin-Based Chemotherapy
por: Herrmann, Jonas, et al.
Publicado: (2021)

Phosphodiesterase SMPDL3B Gene Expression as Independent Outcome Prediction Marker in Localized Prostate Cancer
por: Waldbillig, Frank, et al.
Publicado: (2020)

CDKN2A as transcriptomic marker for muscle-invasive bladder cancer risk stratification and therapy decision-making
por: Worst, Thomas S., et al.
Publicado: (2018)

The prognostic value of galactosylceramide-sulfotransferase (Gal3ST1) in human renal cell carcinoma
por: Porubsky, Stefan, et al.
Publicado: (2021)

Subclassification, survival prediction and drug target analyses of chemotherapy-naïve muscle-invasive bladder cancer with a molecular screening
por: Rinaldetti, Sebastien, et al.
Publicado: (2018)

The EEF1A2 gene expression as risk predictor in localized prostate cancer
por: Worst, Thomas Stefan, et al.
Publicado: (2017)

FOXM1 predicts overall and disease specific survival in muscle-invasive urothelial carcinoma and presents a differential expression between bladder cancer subtypes
por: Rinaldetti, Sebastien, et al.
Publicado: (2017)

mRNA-Expression of KRT5 and KRT20 Defines Distinct Prognostic Subgroups of Muscle-Invasive Urothelial Bladder Cancer Correlating with Histological Variants
por: Eckstein, Markus, et al.
Publicado: (2018)

The Prognostic Value of FGFR3 Expression in Patients with T1 Non-Muscle Invasive Bladder Cancer
por: Sikic, Danijel, et al.
Publicado: (2021)

Prognostic Value of Molecular Breast Cancer Subtypes based on Her2, ESR1, PGR and Ki67 mRNA-Expression in Muscle Invasive Bladder Cancer
por: Kriegmair, M.C., et al.
Publicado: (2018)

FOXA1 Gene Expression for Defining Molecular Subtypes of Muscle-Invasive Bladder Cancer after Radical Cystectomy
por: Sikic, Danijel, et al.
Publicado: (2020)

Natural Language Processing in Diagnostic Texts from Nephropathology
por: Legnar, Maximilian, et al.
Publicado: (2022)

FOXM1 predicts disease progression in non-muscle invasive bladder cancer
por: Rinaldetti, Sebastien, et al.
Publicado: (2018)

Deep learning-based classification of blue light cystoscopy imaging during transurethral resection of bladder tumors
por: Ali, Nairveen, et al.
Publicado: (2021)

The Impact of Small Extracellular Vesicles on Lymphoblast Trafficking across the Blood-Cerebrospinal Fluid Barrier In Vitro
por: Erb, Ulrike, et al.
Publicado: (2020)

A comprehensive molecular characterization of the 8q22.2 region reveals the prognostic relevance of OSR2 mRNA in muscle invasive bladder cancer
por: Uysal, Daniel, et al.
Publicado: (2021)

miR-10a-5p and miR-29b-3p as Extracellular Vesicle-Associated Prostate Cancer Detection Markers
por: Worst, Thomas Stefan, et al.
Publicado: (2019)

IL1RN and KRT13 Expression in Bladder Cancer: Association with Pathologic Characteristics and Smoking Status
por: Worst, Thomas S., et al.
Publicado: (2014)

Host gene and its guest: short story about relation of long-noncoding MIR31HG transcript and microRNA miR-31
por: Kolenda, Tomasz, et al.
Publicado: (2023)

Assessment of glomerular morphological patterns by deep learning algorithms
por: Weis, Cleo-Aron, et al.
Publicado: (2022)

Long noncoding RNA MIR31HG abrogates the availability of tumor suppressor microRNA-361 for the growth of osteosarcoma
por: Sun, Yongjie, et al.
Publicado: (2019)

Long noncoding RNA MIR31HG is a bona fide prognostic marker with colorectal cancer cell‐intrinsic properties
por: Eide, Peter W., et al.
Publicado: (2019)

Re: “Multiparametric cystoscopy: opportunities to enhance bladder cancer detection”
por: Kriegmair, Maximilian Christian, et al.
Publicado: (2020)

KRT20, KRT5, ESR1 and ERBB2 Expression Can Predict Pathologic Outcome in Patients Undergoing Neoadjuvant Chemotherapy and Radical Cystectomy for Muscle-Invasive Bladder Cancer
por: Jütte, Hendrik, et al.
Publicado: (2021)

Xpert bladder cancer monitor to predict the need for a second TURB (MoniTURB trial)
por: Breyer, Johannes, et al.
Publicado: (2023)

Neuropilin-2 and Its Transcript Variants Correlate with Clinical Outcome in Bladder Cancer
por: Förster, Sarah, et al.
Publicado: (2021)

Rapid proteomic analysis for solid tumors reveals LSD1 as a drug target in an end‐stage cancer patient
por: Doll, Sophia, et al.
Publicado: (2018)

Long noncoding RNA MIR31HG exhibits oncogenic property in pancreatic ductal adenocarcinoma and is negatively regulated by miR-193b
por: Yang, H, et al.
Publicado: (2016)

Long noncoding RNA LncHIFCAR/MIR31HG is a HIF-1α co-activator driving oral cancer progression
por: Shih, Jing-Wen, et al.
Publicado: (2017)

Reinvestigating the clinical relevance of the m(6)A writer METTL3 in urothelial carcinoma of the bladder
por: Koch, Jonas, et al.
Publicado: (2023)

Predictive value of molecular subtyping in NMIBC by RT-qPCR of ERBB2, ESR1, PGR and MKI67 from formalin fixed TUR biopsies
por: Breyer, Johannes, et al.
Publicado: (2017)

Changes in neutrophile-to-lymphocyte ratio as predictive and prognostic biomarker in metastatic prostate cancer treated with taxane-based chemotherapy
por: Neuberger, Manuel, et al.
Publicado: (2022)

Systemic inflammatory biomarkers as predictive and prognostic factors in men with metastatic castration-refractory prostate cancer treated with docetaxel therapy: a comprehensive analysis in a German real-world cohort
por: Neuberger, Manuel, et al.
Publicado: (2022)

Long noncoding RNA MIR31HG inhibits hepatocellular carcinoma proliferation and metastasis by sponging microRNA-575 to modulate ST7L expression
por: Yan, Shaoying, et al.
Publicado: (2018)

High Androgen Receptor mRNA Expression Is Independently Associated with Prolonged Cancer-Specific and Recurrence-Free Survival in Stage T1 Bladder Cancer
por: Sikic, Danijel, et al.
Publicado: (2017)

Thymus and autoimmunity
por: Marx, Alexander, et al.
Publicado: (2021)

A multicenter round robin test of PD-L1 expression assessment in urothelial bladder cancer by immunohistochemistry and RT-qPCR with emphasis on prognosis prediction after radical cystectomy
por: Eckstein, Markus, et al.
Publicado: (2018)

Cannot write session to /tmp/vufind_sessions/sess_mbt3f4sh081hfapl6cnvlg1qfa